Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-22

FDA Approved: PITAVASTATIN — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Upsher-Smith's supplemental application for pitavastatin calcium (pitavastatin) under ANDA205955. This action authorizes the marketing of a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PITAVASTATIN CALCIUM (PITAVASTATIN CALCIUM)

Snippet

SUPPL AP for PITAVASTATIN (PITAVASTATIN CALCIUM)